Daily short sale tracking: Sirius XM's short volume increased by 5 million, with a short sale ratio of 37%

Sirius XM(SIRI.US) ranked top of the list had the largest change in short volume (5.63 million shares), and the short volume ratio of FirstEnergy(FE.US) reached 37.85%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.

Moomoo NewsJul 2 09:00 ET

Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 A.m. ET on July 31, 2024

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2024 financial results on Wednesda

Teva PharmaceuticJul 2 00:00 ET

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $21

BofA Securities analyst Jason Gerberry maintains $Teva Pharmaceutical Industries(TEVA.US)$ with a buy rating, and maintains the target price at $21.According to TipRanks data, the analyst has a succes

Moomoo NewsJul 1 21:32 ET · Ratings

Sector Update: Health Care Stocks Slipping in Afternoon Trading

Health care stocks were declining Monday afternoon, with the NYSE Health Care Index down 0.3% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.6%. The iShares Biotechnology ETF (IBB) fell

MT NewswiresJul 1 14:05 ET

Update: Market Chatter: Teva Pharmaceuticals Faces FTC Probe on Patent Listings

(Adds details starting in second paragraph.) Teva Pharmaceutical Industries (TEVA) faces a Federal Trade Commission investigation into the company's alleged refusal to remove two dozen patents for its

MT NewswiresJul 1 10:49 ET

Teva Focus of FTC Investigation Over Inhaler Patents

Seeking AlphaJul 1 10:22 ET